At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Sergio Quezada, PhD, from University College London, London, UK, discusses emerging immunotherapeutic approaches for treating various cancer types. The improved understanding of the underlying principles of cancer biology and immunology, including the mechanisms of checkpoint signalling pathways and actions of immunomodulators, have been an important advance in immunotherapeutic agent development.
Allergy & Immunology
